The main purpose of this legislation is to withdraw the approval of the drug mifepristone, which is used for terminating pregnancies, and to create a legal framework that allows individuals to seek compensation for harm caused by this drug. The law aims to enhance protections for women who may be affected by chemical abortion drugs. Key provisions of the legislation include the immediate withdrawal of mifepristone's approval for use in terminating pregnancies, effective 14 days after the law is enacted. This means that the drug would no longer be legally available for this purpose.